CardioOne Acquires CardioDiagnostics

iRhythm Holdings to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform

August 6, 2026

Healthcare Services

iRhythm Holdings, Inc. entered into a definitive agreement to acquire VitalConnect, a privately held wearable biosensor and ambulatory cardiac monitoring company. The deal is valued at approximately $287.5 million, including about $237.5 million in cash funded from iRhythm’s balance sheet and about $50 million in iRhythm common stock.

Cardio Partners Acquires One Beat Medical & Training

May 14, 2024

Healthcare Services

Cardio Partners, a division of Sarnova and part of Patricia Industries, has acquired One Beat Medical & Training, a Miramar, Florida-based distributor of automated external defibrillators (AEDs), accessories and CPR training services. The transaction, completed May 14, 2024, expands Cardio Partners' emergency preparedness product portfolio and training capabilities while increasing the combined organization's geographic reach across the United States.

WindRose Health Investors Acquires CardioOne

March 4, 2024

Healthcare Services

WindRose Health Investors has completed the acquisition of CardioOne, a physician-enablement company serving independent cardiologists, and partnered with CardioOne's executive team to provide up to $100 million of additional capital to support growth. CardioOne's existing management will remain in place and the investment will fund expansion and enhancement of its technology platform and service offerings as the company prepares for value-based care.

Ucardia Acquires Phas3 to Launch Ucardia-at-Home Remote Cardiac Monitoring

May 8, 2023

Healthcare Services

Ucardia, a cardiac conditioning software developer based in Austin, Texas, has acquired Phas3, a St. Louis-based pioneer in home-based cardiac rehabilitation. The acquisition combines Phas3's remote cardiac rehab software and clinical services with Ucardia's platform to create "Ucardia-at-Home," a comprehensive remote patient monitoring and cardiac rehab offering for providers, payers, and patients.

Mana Capital Acquisition Corp. Completes Business Combination with Cardio Diagnostics (Cardio Diagnostics Holdings, Inc.)

October 26, 2022

Biotechnology

Mana Capital Acquisition Corp. completed its business combination with Cardio Diagnostics, resulting in Cardio Diagnostics Holdings, Inc. being listed on Nasdaq under ticker CDIO (common stock) and CDIOW (warrants). The deal had been supported by a previously announced definitive merger agreement dated May 27, 2022 and required multiple extensions to complete before closing.

Hillrom Acquires Bardy Diagnostics

January 19, 2021

Medical Devices

Hillrom (NYSE: HRC) agreed to acquire Bardy Diagnostics, Inc. (BardyDx) for $375 million in cash plus potential milestone payments, expanding Hillrom's digital health and ambulatory cardiac monitoring capabilities. The deal brings Hillrom a wearable ECG platform (the CAM patch), approximately $30 million in annualized revenue, and about 230 employees; Hillrom expects the acquisition to be dilutive in year one and accretive thereafter.